ABEONA THERAPEUTICS INC. Prepaid Expense and Other Assets, Current
ABEONA THERAPEUTICS INC. (ABEO) had Prepaid Expense and Other Assets, Current of $1.94 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.94M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.95M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.29M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $2.21M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.94M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $1.95M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.29M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.21M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.09M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.01M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.14M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $1.00M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.22M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.81M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $729.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $963.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.20M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.62M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $424.00K 10-K · filed 2024-03-18 | |
| 2022-09-30 | $945.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.44M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.00M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $2.38M 10-K · filed 2023-03-29 | $7.38M 10-K · filed 2022-03-31 |
| 2021-09-30 | $907.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.32M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $1.83M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $2.71M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $689.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $924.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.72M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $3.13M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $1.65M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.34M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $3.37M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $3.80M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $1.98M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $1.94M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.09M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.73M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $1.76M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $867.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $463.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $155.00K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $156.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $206.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $201.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $315.00K 10-K · filed 2017-03-30 | |
| 2015-09-30 | $137.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $222.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $98.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 | |
| 2014-09-30 | $76.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $90.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $82.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $77.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $89.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $292.00K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $242.00K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $251.00K 10-K · filed 2014-03-26 | |
| 2012-09-30 | $28.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $44.00K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $43.00K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $39.00K 10-K · filed 2013-03-20 | |
| 2011-09-30 | $27.00K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $75.00K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $70.00K 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |